Distinct conformational states of SARS-CoV-2 spike protein

Yongfei Cai, Jun Zhang, Tianshu Xiao, +6

Science

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Jun Zhang, Yongfei Cai, Tianshu Xiao, +10

Science

Virus StructureViral ReplicationG614 SpikeMolecular VirologyVaccine Development +10

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

Jun Zhang, Tianshu Xiao, Yongfei Cai, +14

Science

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Yongfei Cai, Jun Zhang, Tianshu Xiao, +16

Science

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

Gary Frey, Hanqin Peng, Sophia Rits‐Volloch, +3

Proceedings of the National Academy of Sciences

Neutralizing AntibodiesImmunologyMolecular BiologyMost AntibodiesEnvelope Glycoprotein +14

Structural basis of coreceptor recognition by HIV-1 envelope spike

Md Munan Shaik, Hanqin Peng, Jianming Lü, +4

Nature

Human RetrovirusImmunologyAntiviral ResponseVirologyHiv-1 Envelope Spike +3

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

Christine A. Bricault, Karina Yusim, Michael S. Seaman, +36

Cell Host & Microbe

HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120

James M. Kovacs, Joseph P. Nkolola, Hanqin Peng, +6

Proceedings of the National Academy of Sciences

Hiv-1 Envelope TrimerAntibody ResponsesMedicineHuman RetrovirusImmunology +11

Structural and functional impact by SARS-CoV-2 Omicron spike mutations

Jun Zhang, Yongfei Cai, Christy L. Lavine, +15

Cell Reports

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

Tianshu Xiao, Jianming Lü, Jun Zhang, +13

Nature Structural & Molecular Biology

Vascular PharmacologyPharmacologyPharmacotherapyMedicineAnti-sars-cov-2 Agent +2